OncoCyte Co. (NASDAQ:OCX) Sees Large Decrease in Short Interest

OncoCyte Co. (NASDAQ:OCX – Free Report) was the recipient of a large decline in short interest in June. As of June 15th, there was short interest totalling 1,070,000 shares, a decline of 24.6% from the May 31st total of 1,420,000 shares. Based on an average daily volume of 335,500 shares, the short-interest ratio is presently […]